Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Can Araman
Advertisement
Can Araman is the principal scientist, biomolecule formulation, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles by Can Araman
Advertisement
Latest Updated Articles
- Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Published: October 7th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
